Work

Cytogenetic and Molecular Drivers of Outcome with Venetoclax-Based Combination Therapies in Treatment-Naïve Elderly Patients with Acute Myeloid Leukemia (AML)

Year: 2018

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2018.07.052

Authors: Stephen A. Strickland, Brenda Chyla, Relja Popovic, Anahita Bhathena, Monique Dail, Yan Sun, Andrew H. Wei, Walter Fiedler, Keith Pratz, John Hayslip, Jalaja Potluri, Courtney D. DiNardo, Daniel A. Pollyea

Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, AbbVie (United States), Genentech, The Alfred Hospital, Monash University, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, University of Colorado Anschutz

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889501479

FWCI: 0.362

Cites:

Cited by: 6

Related to: 10